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INTRODUCTION
A thyroid incidentaloma is defined as a thyroid nodule 
initially discovered by imaging modalities performed for an 
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Objective: To determine the prevalence of thyroid incidentalomas detected by time-resolved magnetic resonance angiography 
(TRMRA) and to evaluate their clinical significance by using an ultrasonographic (US) and cytologic correlation. 
Materials and Methods: We retrospectively reviewed 2010 consecutive TRMRA examinations performed at our institution 
between August 2006 and April 2010. The TRMRA findings of thyroid incidentalomas were analyzed according to location, size, 
as well as vascularity, and were correlated with the US findings and cytologic results. Each nodule was classified as suspiciously 
malignant, indeterminate or probably benign according to the US criteria recommended by the Korean Society of Thyroid 
Radiology. 
Results: A total of 102 incidentalomas were detected in 90 of 2010 patients (5%). TRMRA showed homogenous hypervascularity 
in 48 (47%), inhomogeneous hypervascularity in 46 (45%), and hypovascularity in 8 (8%) thyroid nodules. At follow-up study, 
out of 26 patients with 30 incidentalomas on TRMRA, 27 nodules were identified on US. Of the 27 nodules, 24 (89%) 
nodule were classified as indeterminate, two (7%) as probably benign, and one (4%) as suspiciously malignant. Among the 
16 nodules with available cytopathologic results, 14 (82%) were benign, one (6%) was indeterminate, and one (6%) was 
malignant.
Conclusion: Thyroid incidentalomas are found in 5 % of TRMRA examinations. Although their presence does not necessarily 
indicate malignancy, nonspecific findings of detected incidentalomas on TRMRA require further evaluation by US.
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unrelated purpose. The incidence of thyroid incidentalomas 
continues to rise along with the liberal use and technical 
development of various imaging modalities, such as US, 
computed tomography, and magnetic resonance (MR) 
imaging (1). Contrast enhanced MR angiography has been 
incorporated into the routine examination for neck vessels 
work up due to its high spatial resolution, signal- to-noise 
ratio, and contrast-to-noise ratio (2, 3). In particular, 
with the advent of high performance 3T imaging, time-
resolved MR angiography (TRMRA) has recently become 
popular as it provides both high temporal resolution and 
spatial resolution (4). Using TRMRA, one can obtain images 
at multiple time points, which means that theoretically, 
we could detect any hypervascluar neck tumors within the 
field of view, which can be detected at various time points 
during carotid circulation. Accordingly, in daily clinical Korean J Radiol 13(3), May/Jun 2012 kjronline.org 276
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practice, thyroid incidentalomas have increasingly been 
detected by TRMRA. However, to the best of our knowledge, 
there has only been a single, small-scale report considering 
the frequency of occurrence and the radiologic-pathologic 
correlation for thyroid incidentalomas identified by TRMRA 
(5). 
The objectives of our study were to determine the 
prevalence of thyroid incidentalomas found during TRMRA 
examinations and to evaluate the clinical significance of 
thyroid incidentalomas detected by TRMRA according to the 
relationship with US findings and cytology results. 
MATERIALS AND METHODS
Patients
A total of 2010 subjects underwent TRMRA at 3T between 
August 2006 and April 2010. The subjects consisted of 1042 
men and 968 women aged from 30-88 years (mean age, 
64.3 ± 10.8 years). All examinations were performed as part 
of a preventive health screening or for a risk evaluation 
procedure for cerebrovascular stroke. Twenty-six patients (11 
men and 15 women; mean age 63.7 ± 8.8 years; range 49-
82 years) underwent further US examination of the thyroid. 
Median interval time between TRMRA and thyroid US was 7 
days. Of the 26 patients, 15 underwent an aspiration biopsy 
under US guidance and one patient underwent surgery 
without aspiration biopsy. Five patients did not require an 
aspiration biopsy based on the assessment of their thyroid 
US. Of the 5 patients who did not undergo any further 
workup, one patient refused the aspiration biopsy and 4 
were lost to follow-up.
Our study was approved by our institutional review board. 
As the patients’ data were evaluated retrospectively and 
anonymously, no written informed consent was necessary. 
MR Angiography Technique 
All MR examinations were obtained using a 3T MR scanner 
(Signa HDx; GE Healthcare, Milwaukee, WI, USA) with an 
8-channel head coil. A typical injection protocol consisted 
of a bolus injection of 10 mL of gadobutrol (Gadovist® 1.0, 
Bayer Schering Pharma AG, Berlin, Germany) at a rate of 2.0 
mL/s, followed by flushing with 35 mL of saline bolus at the 
same rate. TRMRA was acquired with a three-dimensional 
gradient echo sequence using a time-resolved method 
(Time-Resolved Imaging of Contrast Kinetics, TRICKS). The 
acquisition parameters for TRMRA were as follows: TR/
TE of 2.704/0.74 ms, flip angle of 20°, matrix 320 x 192, 
slice thickness of 1.6 mm, field of view of 320 mm, and 
a bandwidth of 83.33 kHz. The three-dimensional volume 
acquisitions were coronally oriented with section coverage 
from the aortic arch to the circle of Willis, and laterally to 
both subclavian arteries. Moreover, the volume acquisitions 
were conducted in 13 temporal phases with a temporal 
resolution time of 2.4 seconds and a total scan time of 
approximately 41 seconds. Each three-dimensional image 
set was viewed as coronal maximum intensity projections 
(MIP). 
Ultrasonographic Techniques and Aspiration Biopsies
Two radiologists (W.J.M and N.C, with 11 and 8 years of 
experience of thyroid ultrasound and fine needle aspiration 
[FNA], respectively) performed all ultrasonographic (US) 
examinations and FNA procedures. All US examinations were 
performed using a HDI 5000 (ATL, Ultrasound, Bothell, WA) 
or an IU 22 (Philips Medical Systems, Bothell, WA, USA) 
instrument equipped with either a 7-15 MHz or a 5-12 MHz 
linear array transducer.
Aspiration biopsies were performed by the same 
radiologist who performed the US examination using a 
free-hand technique with a 22 gauge needle and a 5-mL 
disposable plastic syringe. Each nodule was aspirated at 
least twice. 
  
Image Analysis of MR Angiography and Thyroid US
Time-resolved MR angiography and US images of thyroid 
incidentalomas were retrospectively reviewed by two 
radiologists (W.J.M. and N.C), who were blinded to the 
cytopathology results. If there was disagreement, the 
radiologists reached a consensus after a discussion. 
On TRMRA, thyroid incidentalomas were analyzed 
according to their maximal diameter and vascularity. 
The vascularity of a thyroid nodule was categorized as 
homogenously hypervascular (an area of high signal 
intensity more than 90%), inhomogenously hypervascular 
(an area of high signal intensity more than 10% but less 
than 90%), or hypovascular (an area of low signal intensity 
more than 90%), and compared with the vascularity of 
thyroid parenchyma. In patients with cytolopathological 
results, time-signal intensity curves from the TRMRA 
were generated for each thyroid nodule by plotting signal 
intensity of the region of interest (ROI) at the 13 temporal 
phases.
For the incidentalomas in patients who underwent thyroid 
US, the US images were reviewed and the incidentalomas Korean J Radiol 13(3), May/Jun 2012 kjronline.org 277
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were matched to the corresponding nodules on US. US 
characteristics and US diagnoses were prospectively recorded 
and classified according to the standardized lexicon. 
Each nodule was classified as suspiciously malignant, 
indeterminate or probably benign, as recommended by 
the Korean Society of Thyroid Radiology (6, 7). Findings 
suspicious for malignancy on US were defined as having 
at least one of the following features: taller than wide 
shape, spiculated margin, marked hypoechogenicity, or the 
presence of micro- or macrocalcifications. Probably benign 
findings were defined by the presence of a spongiform 
nodule, or of a predominantly cystic mass with a comet-
tail artifact. Indeterminate findings were defined as all US 
findings other than those indicating probable benignity or 
malignancy of a nodule.
Aspiration cytologies were categorized as malignant, 
benign, indeterminate or nondiagnostic. The 
“indeterminate” category encompassed those samples 
demonstrating hypercellularity suggestive of a follicular 
neoplasm, and/or atypical cytoarchitectural features 
suggestive of, but not diagnostic for malignancy.
RESULTS
TRMRA of Thyroid Incidentalomas
A total of 102 thyroid incidentalomas were detected in 90 
(40 males and 50 females; mean age 65.2 ± 10.1 years, 41-
88 years) of the 2010 patients evaluated, a prevalence of 
4.5 %. The mean size of the 102 incidentalomas was 11.3 ± 
6.5 mm (range 3.4-35.0 mm). Forty-eight nodules (47.1%) 
showed homogenous hypervascularity (Fig. 1A); 46 nodules 
(45.1%) showed inhomogenous hypervascularity (Fig. 2A); 
and eight nodules (7.8%) showed hypovascularity (Fig. 3A). 
Correlation with US Appearance and with Cytopathology 
Results of The Thyroid Incidentalomas
Of the 30 incidentalomas (80%) found in the 26 patients 
who underwent subsequent thyroid US, 27 were identified 
by US. The mean size was 12.8 ± 7.8 mm (range 5.0-35.0 
mm). Most incidetalomas (24/27, 88.9%) were classified as 
indeterminate on US (Figs. 1, 2), but two nodules (7.4%) 
were classified as probably benign (Fig. 3), and one nodule 
(3.7%) was classified as suspiciously malignant (Fig. 4). 
A
B
Fig. 1. 58-year-old man with left thyroid nodule, subsequently diagnosed as benign by US-guided FNAB.
A. Coronal MIP image of TRMRA shows left thyroid nodule with homogenous hypervascularity. B. Transverse US image of left thyroid reveals 
smooth, oval, isoechoic, solid nodule, classified as indeterminate. FNAB = fine needle aspiration biopsy, MIP = maximum intensity projections, 
TRMRA = time-resolved MR angiography, US = ultrasonographicKorean J Radiol 13(3), May/Jun 2012 kjronline.org 278
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Of the 27 incidetalomas identified on US, 26 nodules were 
hypervascular (96.3%). Of the 26 hypervascular nodules, 24 
(92.3 %) were classified as indeterminate on thyroid US.
Of the 27 nodules identified on US, 17 were subsequently 
aspirated under US guidance. The cytology results were 
benign in 13 nodules, indeterminate (follicular neoplasm 
of Hurthle cell variant) in one nodule, malignant (papillary 
carcinoma) in one nodule, and of inadequate cytology in 
A B
Fig. 2. 60-year-old man with left thyroid nodule, subsequently diagnosed as benign by US-guided FNAB.
A. Coronal MIP image of TRMRA shows left thyroid nodule with inhomogenous hypervascularity (black lined arrows). B. Longitudinal US image 
of left thyroid reveals smooth, oval, isoechoic predominantly cystic nodule, classified as indeterminate. Internal hypervascular areas (black lined 
arrows on A) correlate with isoechoic solid portion (arrows). MIP = maximum intensity projections, TRMRA = time-resolved MR angiography, US = 
ultrasonographic
A
B
Fig. 3. 66-year-old man with right thyroid nodule.
A. Coronal MIP image of TRMRA shows right thyroid nodule (black lined arrows) with hypovascularity. B. Longitudinal US image of right thyroid 
reveals smooth, oval, isoechoic, predominantly cystic nodule with comet tail artifacts (arrows), which is probably classified as benign nodule. 
MIP = maximum intensity projections, TRMRA = time-resolved MR angiography, US = ultrasonographicKorean J Radiol 13(3), May/Jun 2012 kjronline.org 279
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two nodules. The two nodules with inadequate cytology 
were ultimately diagnosed as being benign following a 
thyroidectomy. The correlation between vascularity on 
TRMRA, US and cytopathology diagnoses are provided in 
Table 1. Two incidental nodules with inadequate cytology 
were initially categorized as indeterminate on the basis of 
US criteria. 
A comparative analysis of the dynamic curves of the 
nonmalignant and malignant nodules is displayed in Fig. 
5. The two dynamic curves did not exhibit any visible 
A
B
Fig. 4. 49-year-old woman with left papillary thyroid carcinoma.
A. Coronal MIP image of TRMRA shows left thyroid nodule (black lined arrow) with homogenous hypovascularity. B. Transverse US image of left 
thyroid shows spiculated, round, hypoechoic, solid nodule, classified as suspicious. MIP = maximum intensity projections, TRMRA = time-resolved 
MR angiography, US = ultrasonographic
Table 1. Correlation with Vascularity on Time-Resolved TRMRA, US Criteria and Cytopathology Diagnoses
n Vascularity on TRMRA n US Criteria n Cytopathology Diagnoses
2 Hypovascular 1 Not identified 1 Not performed
1 Probably benign 1 Not performed
9 Partially hypervascular 1 Probably benign 1 Not performed
8 Indeterminate 4 Not performed
3 FNAB: benign
1 FNAB: follicular neoplasm of the Hurthle cell variant
19 Hypervascular 2 Not identified 2 Not performed
16 Indeterminate 2 Not performed
2 FNAB: inadequate
2 OP: benign
10 FNAB: benign
1 Suspicious 1 FANB: PTC
Note.— TRMRA = time-resolved MR angiography, FNAB = fine needle aspiration biopsy, OP = operation, US = ultrasonographicKorean J Radiol 13(3), May/Jun 2012 kjronline.org 280
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differences. 
DISCUSSION
The widened use of cross-sectional imaging studies such 
as CT or MRI, and their high resolution and sensitivity, have 
led to an increase in the incidental detection of thyroid 
nodules (1). However, few CT- or MRI-based studies have 
reported on the prevalence of incidental thyroid nodules. 
Youserm et al (8) reported that thyroid incidentalomas were 
present in 15.6% of 123 CT scans and 108 MRI examinations 
of the head and neck. A more recent study (9) reported 
thyroid incidentalomas in 16.8% of 734 neck CT scans. 
Meanwhile, a study of 624 TRMRA examinations (5) reported 
a thyroid incidentaloma prevalence of 7.8%, compared to 
4.5% in our study. The lower prevalence may have been 
due to the intrinsically lower resolution of MR angiography 
compared with CT and MRI, and partly due to differences 
in our inclusion criteria. Our study included a substantial 
number of healthy subjects, for whom TRMRA was performed 
as part of a health screening procedure. Conversely, our 
study included the largest population (2010 cases) ever 
evaluated and thus the prevalence of 4.5% from our study 
may be more accurate than other studies.  
While most thyroid incidentalomas are benign, a small 
proportion (5-10%) are malignant (10). A previous study 
suggested a significant prevalence of malignancy of up to 
8.3% among hyperenhancing thyroid incidentalomas on 
TRMRA (5). In contrast, in our study, only one of the 17 
(5.9%) nodules with cytopathologic results was malignant, 
which was a lower incidence than was found in the previous 
study (5). The true incidence rate of malignancy among 
incidentalomas detected on TRMRA could not be determined 
accurately because previous studies have only had a 
small fraction of incidentalomas that were histologically 
examined: 1.9% (12/624) in the study by Lohan et al., 
and 0.8% (17/2010) in our study. The results from these 
two studies suggest that the cancer prevalence for thyroid 
incidentalomas found by TRMRA may be similar to that for 
thyroid incidentalomas found by other imaging modalities 
(11).
Higher intrinsic vascularity compared with the adjacent 
thyroid parenchyma is the most common vascular pattern 
exhibited by papillary thyroid carcinoma (12). Several 
previous studies using color Doppler US have reported that 
a prominent internal or central blood flow within a thyroid 
nodule is indicative of malignancy (13-17). However, 
more recent studies have argued that more than 50% of 
hypervascular nodules are benign (15, 18). Our results 
corroborate with these more recent observations in that 
most thyroid incidentalomas (92.2%) were hypervascular 
but were considered as being benign by either US or fine 
needle aspiration biopsy (FNAB). Therefore, we suggest that 
nodule hypervascularity is a nonspecific finding and does 
not aid pathologic discrimination. 
As expected from the angiogenic nature of all malignant 
tumors, hypovascular papillary carcinomas are uncommon 
(12). In our study, only one of the two hypovascular 
nodules identified by TRMRA was further examined with US, 
the results of which suggested the nodule was benign (Fig. 
3). We could not determine malignancy risk for hypovascular 
nodules detected on TRMRA, from our limited number of 
cases with hypovascular nodules. Given the fact that we do 
not know the risk of malignancy for hypovascular nodules 
identified by TRMRA, it would be reasonable to perform 
follow-up US for hypovascular nodules detected on TRMRA 
in consideration of the patients’ risk factors. 
As only one pathologically proven malignant nodule was 
found in our study, we could not determine any specific 
features on TRMRA distinguishing between benign and 
malignant thyroid nodules. In our study, both benign and 
malignant nodules appeared to have a similar pattern 
regarding a time-signal intensity curve. In a way, TRMRA is 
analogous to dynamic contrast enhanced (DCE) MR imaging, 
as the acquisition of the same slices at multiple time points 
can be achieved using both techniques in such a way that 
time-signal intensity curves can be obtained for a specific 
ROI. Recent studies have documented that the enhancement 
Fig. 5. Graph shows dynamic enhancement curves for 
nonmalignant and malignant nodules. Mean signal intensity of 
16 nonmalignant nodules on same temporal images was used to 
create time-to-signal intensity curve for nonmalignant nodules.
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time-intensity curve of a thyroid nodule on DCE MRI is 
related to its histopathologic features (19, 20). These 
authors suggested that the delayed washout pattern of the 
contrast enhancement was especially relevant for thyroid 
carcinomas. TRMRA could also be used in the evaluation 
of enhancement kinetics similar to DCE MRI. Hence, we 
suggest that a large-scale investigation is required to 
determine whether there is a difference in the enhancement 
kinetics of benign and malignant thyroid nodules.   
In our study, of the 30 incidentalomas (80%) found 
in the 26 patients who underwent subsequent thyroid 
US, 3 nodules in 3 patients were not identified by 
US. We postulate that the causes of this are the small 
size, isoechogenecity or peripheral location of the 
incidentalomas. In addition, all the 3 nodules were not 
notified on the initial radiologic report of TRMRA. Hence, 
thyroid US should have been taken for screening without an 
awareness of the presence of the incidentaloma on TRMRA.
A few limitations to our study should be addressed; first, 
only a relatively small number of TRMRA cases could be 
further examined by using US and cytopathology. This was 
mainly due to the retrospective nature of our study. Second, 
most of the diagnoses were made by cytology rather than 
by histology. A well-designed prospective study including 
consecutive thyroid aspiration biopsies will be needed for 
further investigation of the true clinical significance of 
incidental thyroid nodules found on TRMRA. 
In conclusion, we found thyroid incidentalomas to be 
present in 4.5% (102/2010) of thyroid incidentalomas 
on TRMRA examinations. The frequency of malignancy 
in these lesions was not higher than that of other 
imaging modalities. Thyroid incidentalomas on TRMRA 
did not necessarily indicate malignancy. However, when 
encountering such a lesion in clinical practice, a subsequent 
thyroid US is certainly warranted. 
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